4.6 Article

Obesity and the lung: 3 . Obesity, respiration and intensive care

期刊

THORAX
卷 63, 期 10, 页码 925-931

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/thx.2007.086835

关键词

-

资金

  1. National Institutes of Health [RO1-HL73146, SCOR P50 HL060292, AG024837]
  2. American Heart Association
  3. Respironics
  4. Cephalon
  5. Restore Medical
  6. Apnex Medical
  7. Itamar Medical
  8. Novartis
  9. Inspiration Medical
  10. NMT Medical and Pfizer
  11. National Health and Medical Research Council
  12. Australian Research Council Discovery Grant
  13. ResMed and Inspiration Medical

向作者/读者索取更多资源

Obesity is a major problem from a public health perspective and a difficult practical matter for intensivists. The obesity pandemic has required treating clinicians to develop an appreciation of the substantial pathophysiological effects of obesity on the various organ systems. The important physiological concepts are illustrated by focusing on obstructive sleep apnoea, obesity hypoventilation syndrome, abdominal compartment syndrome and ventilatory management of the obese patient with acute respiratory distress syndrome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据